JDRF CEO Dr. Aaron Kowalski gives an update on some of the incredible advocacy work our 2023 JDRF Children's Congress Delegates are doing on Capitol Hill, as well as a summary of the Senate Hearing that was held this morning. (1/2)

Our future leaders, advocating for the #T1D community. @JDRFgnyc Chuck Schumer Aaron Kowalski JDRF Advocacy #JDRFCC2023

I caught up with JDRF CEO Aaron Kowalski & a young girl with diabetes from Yarmouth, #Maine ahead of their meeting with Congress

150+ kids are testifying for a Diabetes Program extension in Washington on Tuesday

Hear from them on #GoodDayMaine
📺 #CBS13 430a-7a
📺 #FOX23 7a-9a

The course of my life changed 15 years ago when my daughter, Elle, was diagnosed with T1D. Never did I imagine that I would be here right now, but we will not stop until she & the millions of people living with this disease have a cure! Resources & clearly defined regulatory

JDRF-funded researchers Drs. Sarit Polsky, Riitta Veijola, Maria Golson, and Patrice Fort share their key takeaways from day 3 of the American Diabetes Association's Scientific Sessions!

youtu.be/fq4WGIj_85c

Learn more on the blog: bit.ly/3XpxslQ

#ADA2023 #JDRFxADA

1/2 👑We’re delighted to have welcomed Her Majesty The Queen to the UCL Institute of Immunity and Transplantation today where we’re funding research into multiple auto immune conditions.

UCL IIT Royal Free Charity The Royal Family

JDRF is proud to have hosted a joint session with the American Diabetes Association at the 83rd Scientific Sessions around why global screening for type 1 diabetes (T1D) is crucial.

JDRF CEO Dr. Aaron Kowalski discusses how JDRF is helping lead the charge around screening (1/2)

JDRF CEO Dr. Aaron Kowalski shares a few of his key takeaways from the @amdiabetesassn's 83rd Scientific Sessions so far. Be sure to stay tuned over the coming days as we highlight more exciting type 1 diabetes (T1D) research updates. #ada2023 #jdrfxada

Very excited to share JDRF's Day 1 takeaways from #ADA2023 #JDRFxADA . Many exciting developments in #type1diabetes and JDRF has funded more than 140+ of the researchers presenting at this year's sessions. Stay tuned throughout the weekend as we continue to share updates.

Today, JDRF is celebrating Clinical Trials Day! Did you know there are currently over 100 actively recruiting studies for T1D in the U.S.? Clinical trials are essential for delivering new devices and treatments to people with T1D. (1 of2) youtube.com/watch?v=p9g-um…

Apply for the ISPAD - JDRF Fellowship!

This fellowship is for #ISPAD members below age 40 who wish to pursue a career in diabetes-related research. It will cover USD 25,000 in research-related expenses.

Apply here before August 28, 2023: loom.ly/DPUCekE

#JDRF

Half of those diagnosed with T1DM are diagnosed over the age of 18 #ATTD2023

“This is a huge, huge step forward for the field,” says Aaron Kowalski, CEO of type 1 diabetes research organisation JDRF. “It’s the first disease-modifying therapy in type 1 diabetes — ever.” go.nature.com/3YsNz1L

We are encouraged by recent progress, like the $35 dollar monthly cap for those on Medicare included in the Inflation Reduction Act, which is a step in the right direction, but more must be done so those with commercial insurance, the uninsured, and every American who (1/3)

Since our founding, we've been lucky to partner with so many generous & talented individuals in the gaming industry -- including Limited Run Games co-founder Josh Fairhurst!

Learn about Josh's work with JDRF and his #T1D connection: jdrf.org/blog/2023/01/2…

“As a renowned injection device specialist with over 35 years’ experience, Ypsomed will help Civica Rx make self-administered care more affordable for Americans living with diabetes.” businesswire.com/news/home/2023…

Please join us in thanking @ford and Barrett-Jackson for their tremendous and continuous support of JDRF!

Our family's lives have changed for the better thanks to the #wearenotwaiting movement, so I am thrilled to see the FDA authorization of Tidepool Loop! Interoperability and ultimately more Artificial Pancreas options for #T1D which JDRF has championed ...

BREAKING: The U.S. Food and Drug Administration (FDA) authorized the @tidepool_org Loop, an automated insulin dosing app intended for the management of type 1 diabetes (T1D). (1/3)

“He was critical in our understanding of how the body makes insulin & how to better use it,' JDRF's Aaron Kowalski says of renowned UCSF #diabetes researcher Gerold Grodsky, who died in December at age 95. ucsfh.org/3WrjI88